Combination adjuvants: the next generation of adjuvants? G Mutwiri, V Gerdts, S van Drunen Littel-van den Hurk, G Auray, N Eng, ... Expert Review of Vaccines 10 (1), 95-107, 2011 | 126 | 2011 |
Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis S Garlapati, NF Eng, TG Kiros, J Kindrachuk, GK Mutwiri, REW Hancock, ... Vaccine 29 (38), 6540-6548, 2011 | 78 | 2011 |
Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator … S Garlapati, R Garg, R Brownlie, L Latimer, E Simko, REW Hancock, ... Vaccine 30 (35), 5206-5214, 2012 | 72 | 2012 |
The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents NF Eng, S Garlapati, V Gerdts, A Potter, LA Babiuk, GK Mutwiri Current drug delivery 7 (1), 13-20, 2010 | 65 | 2010 |
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies M Polewicz, A Gracia, S Garlapati, J Van Kessel, S Strom, SA Halperin, ... Vaccine 31 (31), 3148-3155, 2013 | 61 | 2013 |
Strategies to link innate and adaptive immunity when designing vaccine adjuvants S Garlapati, M Facci, M Polewicz, S Strom, LA Babiuk, G Mutwiri, ... Veterinary immunology and immunopathology 128 (1-3), 184-191, 2009 | 54 | 2009 |
PCPP (poly [di (carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune … S Garlapati, NF Eng, HL Wilson, R Buchanan, GK Mutwiri, LA Babiuk, ... Vaccine 28 (52), 8306-8314, 2010 | 44 | 2010 |
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens NF Eng, S Garlapati, V Gerdts, LA Babiuk, GK Mutwiri Journal of immune based therapies and vaccines 8, 1-11, 2010 | 32 | 2010 |
van Drunen Littel-van den Hurk, S. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG … S Garlapati, R Garg, R Brownlie, L Latimer, E Simko, RE Hancock, ... Vaccine 30, 5206-5214, 2012 | 30 | 2012 |
Do we know the Th1/Th2/Th17 determinants of vaccine response? S Garlapati Expert Review of Vaccines 11 (11), 1307-1310, 2012 | 14 | 2012 |
Polyphosphazenes enhance mucosal and systemic immune responses in mice immunized intranasally with influenza antigens N F Eng, S Garlapati, K Lai, V Gerdts, GK Mutwiri The Open Vaccine Journal 2 (1), 2009 | 9 | 2009 |
Review Acknowledgements S Akira, S Alam, JM Andrieu, JK Andrus, V Balamurugan, ... Expert Rev. Vaccines 9 (7), 802, 2010 | | 2010 |
Van Ranst M Varga S Venkatesan G Yogisharadhya R Zakay-Rones Z C Ambrose, S Arya, L Aurisicchio, V Balamurugan, R Belshe, G Berbers, ... | | |
Leitner W Li S Loadman R Lopalco P F Lori, A Bandell, A Caputo, P Chong, V Cioce, K Coelingh, F D’Ancona, ... | | |